Why Genetics Matter for Every Dog Owner
You do not need to be a breeder to benefit from understanding canine genetics. Whether you are choosing a puppy, managing a breed-specific health condition, or simply trying to understand your dog’s risk profile, genetics provides the foundation. The choices made by breeders — which dogs to pair, which traits to select for, which health tests to require — determine the health trajectory of entire breeds for generations.
The canine genome was fully sequenced in 2005, and since then the pace of discovery has accelerated dramatically. We now have genetic tests for over 250 heritable diseases in dogs. The tools for responsible breeding have never been more powerful, but adoption of comprehensive testing remains inconsistent across the breeding community.
The Genetic Bottleneck Problem
Most modern dog breeds descend from very small founding populations. The creation of breed registries in the 19th century — and the closed stud books that followed — essentially sealed the gene pool. Every Cavalier King Charles Spaniel alive today descends from just six dogs that survived World War II. The Bernese Mountain Dog population was rebuilt from an extremely small foundation after near-extinction.
This genetic bottleneck creates two problems:
- High coefficient of inbreeding (COI): Breeding within a closed population inevitably increases relatedness. High COI correlates with reduced immune function, lower fertility, and increased expression of recessive diseases.
- Founder effect: Harmful genetic variants present in the founding dogs become disproportionately common in the breed. The extremely high cancer rate in Golden Retrievers and Bernese Mountain Dogs likely reflects oncogene variants that were present in the founding populations and became amplified through generations of closed-population breeding.
What a responsible breeder does:
- Calculates COI for proposed pairings (target: below breed average, ideally under 6.25%)
- Uses genetic diversity testing (UC Davis VGL, Embark for Breeders) to assess heterozygosity
- Considers health and genetic compatibility, not just conformation or title
Essential Health Testing by Breed Type
The OFA (Orthopedic Foundation for Animals) and breed-specific parent clubs define recommended testing panels. At minimum, responsible breeders should complete the Canine Health Information Center (CHIC) requirements for their breed.
Large and Giant Breeds
- Hip evaluation (OFA or PennHIP)
- Elbow evaluation (OFA)
- Cardiac examination (auscultation or echocardiography)
- Ophthalmologic examination (CERF/OFA Eye)
- Breed-specific DNA tests (e.g., degenerative myelopathy for German Shepherds)
Small and Toy Breeds
- Patellar luxation evaluation
- Cardiac examination
- Ophthalmologic examination
- Breed-specific DNA tests (e.g., PRA for Toy Poodles, portosystemic shunt screening for Yorkshire Terriers)
Brachycephalic Breeds
- BOAS assessment (functional grading)
- Cardiac examination
- Patellar luxation evaluation
- Spinal screening for hemivertebrae (screw-tail breeds)
- See the brachycephalic breed health guide
Understanding Genetic Test Results
Genetic tests typically report one of three results for autosomal recessive conditions:
- Clear (N/N): Two normal copies. The dog will not develop the condition and cannot pass the variant to offspring.
- Carrier (N/M): One normal, one mutant copy. The dog will not develop the condition but can pass the variant to 50% of offspring.
- Affected (M/M): Two mutant copies. The dog will likely develop the condition.
Breeding implications:
- Clear x Clear: all puppies clear
- Clear x Carrier: 50% clear, 50% carriers, none affected
- Carrier x Carrier: 25% clear, 50% carriers, 25% affected — this pairing is generally avoided
- Never breed Affected x Affected
For dominant conditions (one copy sufficient to cause disease), any dog carrying the variant is at risk. For X-linked conditions, inheritance patterns differ between males and females.
Key Genetic Tests Every Owner Should Know About
MDR1 (Multi-Drug Resistance 1)
Affects herding breeds primarily. Dogs with one or two copies of the MDR1 mutation cannot properly clear certain drugs from the brain, risking fatal neurotoxicity. Test all herding breeds and herding breed mixes. See the herding breed longevity guide.
Degenerative Myelopathy (DM)
Progressive spinal cord disease affecting older dogs, particularly German Shepherds, Boxers, Pembroke Welsh Corgis, and Rhodesian Ridgebacks. The SOD1 gene test identifies at-risk dogs, though penetrance is incomplete (not all M/M dogs develop clinical disease).
Exercise-Induced Collapse (EIC)
Common in Labrador Retrievers. Dogs with two copies of the DNM1 gene variant experience collapse during intense exercise. Identifiable by genetic test, manageable by avoiding sustained intense activity.
Von Willebrand Disease
Bleeding disorder caused by deficiency in von Willebrand factor. Multiple types affect different breeds. Testing is essential before any surgical procedure in affected or at-risk breeds.
Progressive Retinal Atrophy (PRA)
Group of inherited retinal degenerations causing progressive blindness. Multiple genetic variants across breeds. Test panels exist for breed-specific PRA types. See the PRA condition guide.
Coefficient of Inbreeding: The Number That Matters
The coefficient of inbreeding (COI) measures the probability that two alleles at any locus are identical by descent — essentially, how related the parents are. A COI of 25% represents a parent-offspring or full-sibling mating. A COI of 12.5% represents a half-sibling mating.
Impact of high COI:
- Reduced immune competence (smaller, less diverse MHC/DLA complex)
- Decreased fertility and smaller litter sizes
- Increased expression of recessive disease alleles
- Shorter lifespan — studies have shown a direct correlation between COI and reduced longevity
What buyers should look for:
- Breeders who calculate and disclose COI for each litter
- COI below the breed average
- Breeders who use tools like Embark for Breeders, MyDogDNA, or breed-specific databases to assess genetic diversity
- Openness about breed-wide health challenges rather than claiming their line is “health-tested” without specifics
The Role of Genetic Testing for Pet Owners
Even if you are not breeding, genetic testing provides actionable health information:
Benefits of consumer genetic testing (Embark, Wisdom Panel):
- Breed identification for mixed-breed dogs — relevant for breed-specific health screening
- Carrier status for heritable conditions — informs veterinary management
- Drug sensitivity (MDR1) — potentially life-saving
- Genetic diversity assessment — context for immune function
- Coefficient of inbreeding — context for overall genetic health
Limitations:
- Genetic risk does not equal destiny — many conditions have incomplete penetrance
- Environmental factors, nutrition, and management significantly modify genetic risk
- Not all heritable conditions have identified genetic markers
- New variants are continuously discovered; testing panels evolve
Choosing a Responsible Breeder
If purchasing a puppy, evaluate breeders on health testing practices:
Green flags:
- All recommended CHIC tests completed and results publicly available on OFA database
- COI calculated for each pairing
- Health guarantees backed by documentation
- Transparency about breed health challenges
- Willingness to take dogs back if the owner cannot keep them
- Limited breeding frequency (no more than 1-2 litters per year per dam)
Red flags:
- “Our dogs are healthy” without specific test documentation
- No OFA or genetic test results available
- Multiple litters available simultaneously
- No questions asked of puppy buyers
- “Rare color” breeding (often associated with higher health risk variants)
Medical Disclaimer
This guide is for informational purposes only and does not constitute veterinary or breeding advice. Breeding decisions should involve consultation with veterinary geneticists and breed health committees. Genetic test results should be interpreted in partnership with your veterinarian.
Frequently Asked Questions
Should I get my pet dog genetically tested? Yes, genetic testing is valuable even for pet dogs. It identifies breed-specific health risks, drug sensitivities (MDR1), and carrier status for heritable conditions. This information helps your veterinarian tailor preventive care. The cost ($100-$250 for comprehensive panels) is modest relative to the value of the information.
What is a good coefficient of inbreeding? Lower is better. A COI under 6.25% is a reasonable target, though many purebred dogs exceed this due to closed stud books. COIs above 12.5% are associated with measurable health impacts. When evaluating a breeder, ask for the COI calculation and compare it to the breed average.
Why do some breeds have so many health problems? Closed stud books, small founding populations, selection for extreme physical traits (very flat faces, very long backs, very large or small size), and popular sire effects (a few males producing disproportionate numbers of offspring) have concentrated harmful genetic variants in certain breeds. This is a structural problem that requires breed-level solutions, not just individual breeder choices.
Is genetic testing accurate? For well-characterized variants with validated assays, genetic testing is highly accurate (typically >99%). However, negative results do not guarantee a dog will never develop a condition — many diseases involve multiple genes and environmental factors. Testing identifies known risks, not all possible risks.
Can genetic testing predict my dog’s lifespan? Not directly. Genetic testing identifies specific disease risks that may affect lifespan, but longevity is determined by the complex interaction of genetics, environment, nutrition, medical care, and chance. Genetic testing is one tool among many for optimizing your dog’s health trajectory.